Adverum Biotechnologies, Inc. AVU.F Stock
Adverum Biotechnologies, Inc. Price Chart
Adverum Biotechnologies, Inc. AVU.F Financial and Trading Overview
| Adverum Biotechnologies, Inc. stock price | 1.48 EUR |
| Previous Close | 1.33 EUR |
| Open | 1.3 EUR |
| Bid | 1.3 EUR x 210000 |
| Ask | 1.37 EUR x 210000 |
| Day's Range | 1.3 - 1.3 EUR |
| 52 Week Range | 0.5 - 1.74 EUR |
| Volume | 229 EUR |
| Avg. Volume | 7 EUR |
| Market Cap | 134.96M EUR |
| Beta (5Y Monthly) | 0.709507 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.57 EUR |
AVU.F Valuation Measures
| Enterprise Value | 67.09M EUR |
| Trailing P/E | N/A |
| Forward P/E | -1.015625 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 37.488747 |
| Price/Book (mrq) | 0.8285532 |
| Enterprise Value/Revenue | 18.637 |
| Enterprise Value/EBITDA | -0.494 |
Trading Information
Adverum Biotechnologies, Inc. Stock Price History
| Beta (5Y Monthly) | 0.709507 |
| 52-Week Change | 45.56% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.74 EUR |
| 52 Week Low | 0.5 EUR |
| 50-Day Moving Average | 0.82 EUR |
| 200-Day Moving Average | 0.77 EUR |
AVU.F Share Statistics
| Avg. Volume (3 month) | 7 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 100.58M |
| Float | 78.35M |
| Short Ratio | N/A |
| % Held by Insiders | 3.70% |
| % Held by Institutions | 63.54% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3956.027% |
| Gross Margin | -44.52% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -26.065% |
| Return on Equity (ttm) | -66.11% |
Income Statement
| Revenue (ttm) | 3.6M EUR |
| Revenue Per Share (ttm) | 0.04 EUR |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -135722000 EUR |
| Net Income Avi to Common (ttm) | -145684000 EUR |
| Diluted EPS (ttm) | -1.35 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 164.28M EUR |
| Total Cash Per Share (mrq) | 1.63 EUR |
| Total Debt (mrq) | 97.61M EUR |
| Total Debt/Equity (mrq) | 61.88 EUR |
| Current Ratio (mrq) | 3.634 |
| Book Value Per Share (mrq) | 1.569 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -101574000 EUR |
| Levered Free Cash Flow (ttm) | -66778624 EUR |
Profile of Adverum Biotechnologies, Inc.
| Country | Germany |
| State | CA |
| City | Redwood City |
| Address | 100 Cardinal Way |
| ZIP | 94063 |
| Phone | (650) 656-9323 |
| Website | https://adverum.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 123 |
Adverum Biotechnologies, Inc., a clinical-stage company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ixoberogene soroparvovec (ADVM-022), a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. The company is developing ADVM-062 (AAV.7m8-L-opsin), a novel gene therapy product candidate for the treatment of blue cone monochromacy via a single IVT injection. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; GenSight Biologics; Lexeo Therapeutics; and Virovek, Inc. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.
Q&A For Adverum Biotechnologies, Inc. Stock
What is a current AVU.F stock price?
Adverum Biotechnologies, Inc. AVU.F stock price today per share is 1.48 EUR.
How to purchase Adverum Biotechnologies, Inc. stock?
You can buy AVU.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Adverum Biotechnologies, Inc.?
The stock symbol or ticker of Adverum Biotechnologies, Inc. is AVU.F.
Which industry does the Adverum Biotechnologies, Inc. company belong to?
The Adverum Biotechnologies, Inc. industry is Biotechnology.
How many shares does Adverum Biotechnologies, Inc. have in circulation?
The max supply of Adverum Biotechnologies, Inc. shares is 207.55M.
What is Adverum Biotechnologies, Inc. Price to Earnings Ratio (PE Ratio)?
Adverum Biotechnologies, Inc. PE Ratio is 0.00000000 now.
What was Adverum Biotechnologies, Inc. earnings per share over the trailing 12 months (TTM)?
Adverum Biotechnologies, Inc. EPS is 0 EUR over the trailing 12 months.
Which sector does the Adverum Biotechnologies, Inc. company belong to?
The Adverum Biotechnologies, Inc. sector is Healthcare.